127 related articles for article (PubMed ID: 2986882)
1. Cardiovascular effects of a renin inhibitor in relation to posture in nonhuman primates.
Pals DT; DeGraaf GL; Kati WM; Lawson JA; Smith CW; Skala GF
Clin Exp Hypertens A; 1985; 7(1):105-21. PubMed ID: 2986882
[TBL] [Abstract][Full Text] [Related]
2. Specific inhibition of renin by an angiotensinogen analog: studies in sodium depletion and renin-dependent hypertension.
Burton J; Cody RJ; Herd JA; Haber E
Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5476-9. PubMed ID: 6159648
[TBL] [Abstract][Full Text] [Related]
3. Additive combination studies of captopril and ditekiren, a renin inhibitor, in nonhuman primates.
Pals DT; DeGraaf GL; Couch SJ; Brunden MN
Clin Exp Hypertens A; 1991; 13(3):425-36. PubMed ID: 1893613
[TBL] [Abstract][Full Text] [Related]
4. Renin--angiotensin antagonists and the regulation of blood pressure.
Samuels AI; Miller ED; Fray JC; Haber E; Barger AC
Fed Proc; 1976 Nov; 35(13):2512-20. PubMed ID: 185095
[TBL] [Abstract][Full Text] [Related]
5. An orally active inhibitor of renin.
Pals DT; Thaisrivongs S; Lawson JA; Kati WM; Turner SR; DeGraaf GL; Harris DW; Johnson GA
Hypertension; 1986 Dec; 8(12):1105-12. PubMed ID: 3539793
[TBL] [Abstract][Full Text] [Related]
6. Systemic and renal haemodynamic effects of renin or angiotensin converting enzyme inhibition in non-human primates.
Pals DT; Ludens JH; DeGraaf GL
J Hypertens Suppl; 1989 Apr; 7(2):S43-6. PubMed ID: 2666613
[TBL] [Abstract][Full Text] [Related]
7. Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin.
Case DB; Wallace JM; Keim HJ; Weber MA; Drayer JI; White RP; Sealey JE; Laragh JH
Am J Med; 1976 Nov; 61(5):790-6. PubMed ID: 185903
[TBL] [Abstract][Full Text] [Related]
8. Hypotensive effects of the renin inhibitor (RI-78) and the converting enzyme inhibitor (teprotide) in conscious monkeys.
Takaori K; Hartley LH; Burton J
Clin Exp Hypertens A; 1987; 9(2-3):387-90. PubMed ID: 3038400
[TBL] [Abstract][Full Text] [Related]
9. The role of the renin-angiotensin-aldosterone system in cardiovascular homeostasis in normal human subjects.
Sancho J; Re R; Burton J; Barger AC; Haber E
Circulation; 1976 Mar; 53(3):400-5. PubMed ID: 174834
[TBL] [Abstract][Full Text] [Related]
10. Hormonal and cardiovascular effects of losulazine hydrochloride in relation to sodium balance in nonhuman primates.
Pals DT
Clin Exp Hypertens A; 1986; 8(7):1179-88. PubMed ID: 3533328
[TBL] [Abstract][Full Text] [Related]
11. Renin vs. angiotensin-converting enzyme inhibition in the rat: consequences for plasma and renal tissue angiotensin.
Allan DR; Hui KY; Coletti C; Hollenberg NK
J Pharmacol Exp Ther; 1997 Nov; 283(2):661-5. PubMed ID: 9353383
[TBL] [Abstract][Full Text] [Related]
12. Effects of chronic infusion of renin inhibitor A-64662 in sodium-depleted monkeys.
Verburg KM; Kleinert HD; Kadam JR; Chekal MA; Mento PF; Wilkes BM
Hypertension; 1989 Mar; 13(3):262-72. PubMed ID: 2646217
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of renin: recent developments.
Hofbauer KG; Wood JM
Contrib Nephrol; 1984; 43():144-52. PubMed ID: 6207982
[No Abstract] [Full Text] [Related]
14. Pharmacological study of SR 47436, a non-peptide angiotensin II AT1-receptor antagonist, in conscious monkeys.
Lacour C; Roccon A; Cazaubon C; Segondy D; Nisato D
J Hypertens; 1993 Nov; 11(11):1187-94. PubMed ID: 8301099
[TBL] [Abstract][Full Text] [Related]
15. Blockade of renin or angiotensin for understanding human hypertension: a comparison of propranolol, saralasin and converting enzyme blockade.
Laragh JH; Case DB; Wallace JM; Keim H
Fed Proc; 1977 Apr; 36(5):1781-7. PubMed ID: 191300
[TBL] [Abstract][Full Text] [Related]
16. Peptide inhibitors of renin in cardiovascular studies.
Haber E
Fed Proc; 1983 Dec; 42(15):3155-61. PubMed ID: 6196232
[TBL] [Abstract][Full Text] [Related]
17. Hormonal and cardiovascular effects of losartan (DuP753), an angiotensin receptor antagonist, in nonhuman primates.
DeGraaf GL; Pals DT; Couch SJ; Lawson JA
J Pharmacol Exp Ther; 1993 Jan; 264(1):6-10. PubMed ID: 8423551
[TBL] [Abstract][Full Text] [Related]
18. Combined renin and converting enzyme inhibition in rats.
Mento PF; Holt WF; Murphy WR; Wilkes BM
Hypertension; 1989 Jun; 13(6 Pt 2):741-8. PubMed ID: 2661429
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of the blood pressure lowering action of renin inhibition and comparison with angiotensin converting enzyme inhibition.
Blaine EH
J Hypertens Suppl; 1989 Apr; 7(2):S47-9. PubMed ID: 2666614
[TBL] [Abstract][Full Text] [Related]
20. Comparative effects of three different potent renin inhibitors in primates.
Clozel JP; Fischli W
Hypertension; 1993 Jul; 22(1):9-17. PubMed ID: 8319997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
